Search
NVIDIA-Backed AI Drug Discovery Company Iambic Files for U.S. IPO
2 day ago /
Read about 0 minute
Author：小编
On Monday local time, Iambic Therapeutics, an AI-driven pharmaceutical company backed by NVIDIA and Qatar's sovereign wealth fund, officially filed for its initial public offering (IPO) in the United States. Despite a rocky start to the autumn IPO window in the U.S. stock market, analysts believe that listing activities among biotechnology firms have not been significantly affected. This year, a surge in acquisitions by major pharmaceutical companies has provided strong support for industry listing activities. Drug developers Retension Pharmaceuticals and TRex Bio filed for U.S. IPOs last Friday, while ADARx Pharmaceuticals also kicked off its roadshow earlier on Monday.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
